Effect upon hospital activity of the application of a continued care model centered on patients with inflammatory bowel disease

Revista Espanola de Enfermedades Digestivas

Volumn 104, Issue 1, 2012, Pages 16-20

  Casellas Jordá, Francesc ^a   Borruel Sainz, Natalia ^a   Torrejón Herrera, Antonio ^a   Castells, Isabel ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Continued care; Crohn's disease; Hospital admissions; IBD unit; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

ADULT; ARTICLE; COMPARATIVE STUDY; CROHN DISEASE; FEMALE; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HOSPITAL CARE; HOSPITAL PATIENT; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT CARE; RETROSPECTIVE STUDY; ULCERATIVE COLITIS;

EID: 84856663408     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1130-01082012000100004     Document Type: Article

References (18)

1. Pajares JM, Gisbert JP. Epidemiology of inflammatory bowel disease in Spain. A systematic review. Rev Esp Enferm Dig 2001;93:9-20.
2. López-Serrano P, Pérez-Calle JL, Carrera-Alonso E, Pérez-Fernández T, Rodríguez-Caravaca G, Boixeda-de-Miguel D, et al. Epidemiologic study on the current incidence of inflammatory bowel disease in Madrid. Rev Esp Enferm Dig 2009;101:768-72.
3. Arin Letamendia A, Borda Celaya F, Burusco Paternain MJ, Prieto Martínez C, Martínez Echeverría A, Elizalde Apestegui I, et al. High incidence rates of inflammatory bowel disease in Navarra (Spain). Results of a prospective, population-based study. Gastroenterol Hepatol 2008;31:111-6.
4. Phan VA, van Langenberg DR, Grafton R, et al. Introduction of a dedicated IBD service quantitatively and qualitatively improves outcomes in less than 18 months: a prospective cohort study in a large metropolitan centre. Gastroenterology 2010;138(Supl. 1): S318.
5. Fontanet G, Casellas F, Malagelada JR. The Crohn-Colitis care unit: analysis of the first 3 years of activity. Gac Sanit 2004;18:483-5.
6. Casellas F, Fontanet G, Borruel N, Malagelada JR. The opinion of patients with inflammatory bowel disease on healthcare received. Rev Esp Enferm Dig 2004;96:174-84.
7. Torrejón A, Masachs M, Borruel N, Castells I, Castillejo N, Malagelada JR, et al. Aplicación de un modelo de asistencia continuada en la enfermedad inflamatoria intestinal: la Unidad de Atención Crohn-Colitis. Gastroenterol Hepatol 2009;32:77-82.
8. Masachs M, Casellas F, Borruel N, Torrejón A. Castells I, Malagelada JR. Validation of the Spanish version of a questionnaire to measure quality of care through the eyes of patients with inflammatory bowel disease (QUOTE-IBD). Inflamm Bowel Dis 2010;16:982-92.
9. Weiss ST. The hygiene hypothesis and allergic diseases. New Engl J Med 2002;347:930-1.
10. Casellas F, Panés J, García-Sánchez V, Ginard D, Gomollón F, Hinojosa J, et al. A. Costes médicos directos de la enfermedad de Crohn en España. Pharmacoeconomics-Spanish Research Articles 2010;7:38-46.
11. Bewtra M, Su C, Lewis JD. Trends in hospitalization rates for inflammatory bowel disease in the United States. Clin Gastroenterol Hepatol 2007;5:597-601.
12. Nguyen GC, Sam J, Murthy SK, Kaplan GG, Tinmouth JM, LaVeist TA Hospitalizations for inflammatory bowel disease: profile of the uninsured in the United States. Inflamm Bowel Dis 2009;15:726-33.
13. Nguyen GC, Steinhart AH. Nationwide patterns of hospitalizations to centers with high volume of admissions for inflammatory bowel disease and their impact on mortality. Inflamm Bowel Dis 2008;14:1688-94.
14. Wang YR, Cangemi JR, Picco MF. Changing Trends of Hospitalizations for Inflammatory Bowel Disease in the United States, 1993-2007. Gastroenterology 2010;138(Supl. 1):S531-S532.
15. Robinson A, Thompson DG, Wilkin D, Roberts C, for the Northwest Gastrointestinal Research Group. Guided self-management and patientdirected follow-up of ulcerative colitis: a randomised trial. Lancet 2001;358:976-81.
16. Kennedy AP, Nelson E, Reeves D, Richardson G, Roberts C, Robinson A, et al. A randomised controlled trial to assess the effectiveness and cost of a patient orientated self management approach to chronic inflammatory bowel disease. Gut 2004;53:1639-45.
17. Richardson G, Sculpher M, Kennedy A, Nelson E, Reevers D, Roberts C, et al. Is self-care a cost-effective use of resources? Evidence from a randomized trial in inflammatory bowel disease. J Health Serv Res Policy 2006;11:225-30.
18. Taxonera C, Rodrigo L, Casellas F, Calvet X, Gómez-Camacho F, Ginard D, et al. Infliximab maintenance therapy is associated with decreases in direct resource use in patients with luminal or fistulizing Crohn's disease. J Clin Gastroenterol 2009;43:950-6.